Dr. Julio A. Miranda, the founder of Sleep Panama, is an American-trained doctor. He is a specialist in Internal Medicine, Pulmonology (diseases of the lungs), and Critical Care Medicine with special training in diseases and disorders of sleep at the Sleep Disorders Center of Dartmouth Medical School in New Hampshire, USA.

Download Curriculum Vitae


  4/97-3/00 Instructor of Medicine - University of Panama
Assistant Professor of Medicine - University of Panama
Instructor of Medicine - Rush University, Chicago, Illinois
Instructor of Medicine, Critical Care and Pulmonary Physiology - Dartmouth Medical School, Hanover, New Hampshire



2/96-3/97 Panamanian Association for Family Planning (APLAFA)
Changuinola, Bocas del Toro, Republica de Panama - Medical Director

1/01-4/01 Hospital Complex of the CSS, Panama City, Panama -
Selection Committee for Internal Medicine Residents

2001 Applied Computing Center of the Social Security Fund - Member

6/04-7/05 Applicants Selection Committee for Internal Medicine Residency at Cook County Hospital, Chicago, Illinois - Reviewer

6/04-7/05 Promotions Committee Program Resident Internal Medicine Cook County Hospital, Chicago, Illinois - Member Evaluator


Journal Articles:
Original Articles (Peer Reviewed):

  • Trick WE, Miranda JA, Evans A, Charles-Damte M, Reilly BM, Clarke P. Prospective cohort study of central venous catheters among internal medicine ward patients. American Journal of Infection Control. 2006 Dec;34(10):636-41.
  • Miranda JA, Trick WE, Evans AT, Charles-Damte M, Reilly BM, Clarke P. Firm-based trial to improve central venous catheter insertion practices. Journal of Hospital Medicine. 2007 May;2(3):135-42.
  • Miranda JA, Ernst A. Complications in interventional pulmonology. Minerva Pneumologica. 2007 June:46 (2):109-21.


  • Miranda JA. Pulmonary Vein Thrombosis Presenting as Myocardial Infarction. CHEST. 2006 October 130 (4 Suppl): 344S.

Clinical Trials:

  • A randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability to indacaterol in patients with COPD using formoterol and tiotropium. Novartis Pharmaceutical Corporation. Approved on 6/1/2007 at Dartmouth Hitchcock Medical Center. Sub-Principal Investigator.

Approved Research by Dartmouth Medical School (currently under preparation):

  • Safety and Tolerability of Inhaled Hypertonic Saline in Cystic Fibrosis Patients with Severe. Prospective Study. Principal Investigator: Julio A. Miranda.
  • Early mortality (less than 24 hours) in the Intensive Care Unit of the Hospital of Dartmouth College in the period 2001 to 2007. New Hampshire, USA. Principal Investigator: Julio A. Miranda
Todos los Derechos Reservados por CEMPYS © Copyright 2009
Diseñado por: Sistemas TL, S.A.